Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
ADMA Biologics Inc (ADMA) had Normalized Pre-Tax Income of $57.13M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$114.49M |
|
$45.33M |
|
$33.74M |
|
$80.75M |
|
$56.22M |
|
$58.27M |
|
$-1.15M |
|
$57.13M |
|
|
Normalized Pre-Tax Income |
$57.13M |
$45.33M |
|
$45.33M |
|
$45.33M |
|
$45.33M |
|
$58.27M |
|
$60.27M |
|
236.07M |
|
239.96M |
|
$0.19 |
|
$0.19 |
|
| Balance Sheet Financials | |
$511.17M |
|
$65.01M |
|
$154.01M |
|
$665.18M |
|
$73.54M |
|
$199.95M |
|
$201.32M |
|
$274.86M |
|
$390.32M |
|
$386.17M |
|
$390.32M |
|
232.29M |
|
| Cash Flow Statement Financials | |
$58.25M |
|
$2.40M |
|
$-10.13M |
|
$87.63M |
|
$138.15M |
|
$50.52M |
|
$6.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.95 |
|
-- |
|
-- |
|
0.34 |
|
0.52 |
|
70.53% |
|
50.90% |
|
50.90% |
|
-- |
|
49.90% |
|
39.59% |
|
$60.71M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
0.15 |
|
0.84 |
|
106.80 |
|
11.61% |
|
11.74% |
|
6.81% |
|
7.68% |
|
$1.68 |
|
$0.25 |
|
$0.24 |
|